Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2022.1091668 Immunology Correction Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions Schriek Angela I. 1 van Haaren Marlies M. 1 Poniman Meliawati 1 Dekkers Gillian 2 Bentlage Arthur E. H. 3 Grobben Marloes 1 Vidarsson Gestur 3 Sanders Rogier W. 1 4 Verrips Theo 5 6 Geijtenbeek Teunis B. H. 7 Heukers Raimond 2 Kootstra Neeltje A. 7 de Taeye Steven W. 1 * van Gils Marit J. 1 * 1 Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands 2 QVQ Holding BV, Utrecht, Netherlands 3 Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands 4 Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States 5 Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands 6 VerLin BV, Utrecht, Netherlands 7 Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Marit J. van Gils, m.j.vangils@amsterdamumc.nl; Steven W. de Taeye, s.w.detaeye@amsterdamumc.nl

This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology

 22 11 2022 2022 13 1091668 07 11 2022 09 11 2022 Copyright © 2022 Schriek, van Haaren, Poniman, Dekkers, Bentlage, Grobben, Vidarsson, Sanders, Verrips, Geijtenbeek, Heukers, Kootstra, de Taeye and van Gils 2022 Schriek, van Haaren, Poniman, Dekkers, Bentlage, Grobben, Vidarsson, Sanders, Verrips, Geijtenbeek, Heukers, Kootstra, de Taeye and van Gils

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions by Schriek AI, van Haaren MM, Poniman M, Dekkers G, Bentlage AEH, Grobben M, Vidarsson G, Sanders RW, Verrips T, Geijtenbeek TBH, Heukers R, Kootstra NA, de Taeye SW and van Gils MJ (2022) Front. Immunol. 13:893648. doi: 10.3389/fimmu.2022.893648 HIV-1 nanobodies neutralization Fc fusion Fc-mediated effector functions

In the published article, there was an error in the Funding statement. The funder was mentioned as AIDSfonds and Aids fonds instead of Aidsfonds. The correct Funding statement appears below.

Funding

This work was supported by HealthHolland/Aidsfonds: LSHM19101/P-44802, by HealthHolland/AMC: 2019-1167 and the AMC Fellowship from Amsterdam UMC received by MJG. ST is supported by Young investigator grant P-53301 Aidsfonds.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.